| +0.07 / +1.85%|
TearLab Corp. is an in vitro diagnostic company, which develops ophthalmic devices. The company commercializes proprietary in vitro diagnostic tear testing platform, the TearLab test for dry eye disease, or DED, which enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in San Diego, CA.
|Elias Vamvakas||Chairman, Chief Executive Officer & Secretary|
|Joseph Jensen||President & Chief Operating Officer|
|William G. Dumencu||Chief Financial Officer & Treasurer|
|Benjamin D. Sullivan||Chief Scientific Officer|
|Stephen G. Zmina||Vice President-Manufacturing & Engineering|